Instead, the FDA granted Aduhelm a conditional approval, allowing it to be prescribed and used while Biogen conducts a post-marketing, phase 4 confirmatory study – which could take years to ...

For a 4-week supply of the weekly injections, the discount at LillyDirect translates to $399 for a 2.5-mg single-dose vial ($99.75 per vial) and $549 for the 5-mg dose ($137.25 per vial), which ...

Donanemab was approved as a 300 mg/20 mL single-dose vial in patients with a confirmed ... Biogen’s decision to discontinue aducanumab (Aduhelm), effective November 2024. 10 The FDA granted ...

Steriline, an Italian manufacturer of highly specialized production equipment for the pharmaceutical industry, unveils its new RVFCM11-S Robotic Vial Filling & Capping Machine, which is poised to ...

This form of Zepbound is sold as a vial that needs to be given by a syringe, although patients can still do it themselves. Zepbound and Mounjaro are both brand names for tirzepatide. However ...

To sign up for Becker's Pharmacy Report E-Newsletter or any of our other E-Newsletters, click here. If you are experiencing difficulty receiving our newsletters, you may need to whitelist our new ...

The US Centres for Medicare and Medicaid Services (CMS) has firmed up its draft decision to limit reimbursement of Biogen's Alzheimer's disease therapy Aduhelm to a few thousand patients enrolled ...